The effect of prior cancer on non‐small cell lung cancer trial eligibility

OBJECTIVES: Approximately 20% of patients diagnosed with non‐small cell lung cancer (NSCLC) have a history of prior (non‐lung) cancer. Patients with prior cancer are frequently excluded from clinical trials. We aimed to assess the potential impact of prior cancer on commonly used clinical trial endp...

Descripción completa

Detalles Bibliográficos
Autores principales: Herman, Michael, Liu, Zhihui, Shepherd, Frances A., Leighl, Natasha, Liu, Geoffrey, Bradbury, Penelope A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290254/
https://www.ncbi.nlm.nih.gov/pubmed/34145985
http://dx.doi.org/10.1002/cam4.4049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290254/
https://www.ncbi.nlm.nih.gov/pubmed/34145985
http://dx.doi.org/10.1002/cam4.4049

Ejemplares similares